These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 27128402)

  • 1. [Strong and Deficient Evidence in Drug-Treated, Non-Tumorous Diseases in ENT].
    Bas M
    Laryngorhinootologie; 2016 Apr; 95 Suppl 1():S217-32. PubMed ID: 27128402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence and evidence gaps of medical treatment of non-tumorous diseases of the head and neck.
    Bas M
    GMS Curr Top Otorhinolaryngol Head Neck Surg; 2016; 15():Doc02. PubMed ID: 28025602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment of Meniere's disease.
    Slattery WH; Fayad JN
    Otolaryngol Clin North Am; 1997 Dec; 30(6):1027-37. PubMed ID: 9386239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate.
    Nielsen EW; Gramstad S
    Acta Anaesthesiol Scand; 2006 Jan; 50(1):120-2. PubMed ID: 16451161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED.
    Bartal C; Zeldetz V; Stavi V; Barski L
    Am J Emerg Med; 2015 Mar; 33(3):479.e1-3. PubMed ID: 25241359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tongue angioedema associated with angiotensin-converting enzyme inhibitor (diagnosis, differential diagnosis, treatment)].
    Satkiene D; Kavoliūniene A; Petrauskiene I; Sirvyte R
    Medicina (Kaunas); 2003; 39(6):570-3. PubMed ID: 12829880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiotensin-converting enzyme inhibitor-related angioedema: emergency treatment with complement C1 inhibitor concentrate].
    Gelée B; Michel P; Haas R; Boishardy F
    Rev Med Interne; 2008 Jun; 29(6):516-9. PubMed ID: 18096274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ACE-inhibitor induced angioedema].
    Bas M; Hoffmann TK; Kojda G; Bier H
    Laryngorhinootologie; 2007 Nov; 86(11):804-8, quiz 809-13. PubMed ID: 17966084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema.
    Warner KK; Visconti JA; Tschampel MM
    Ann Pharmacother; 2000 Apr; 34(4):526-8. PubMed ID: 10772441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fresh frozen plasma for progressive and refractory angiotensin-converting enzyme inhibitor-induced angioedema.
    Hassen GW; Kalantari H; Parraga M; Chirurgi R; Meletiche C; Chan C; Ciarlo J; Gazi F; Lobaito C; Tadayon S; Yemane S; Velez C
    J Emerg Med; 2013 Apr; 44(4):764-72. PubMed ID: 23114109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema.
    Beavers CJ; Dunn SP; Macaulay TE
    Ann Pharmacother; 2011 Apr; 45(4):520-4. PubMed ID: 21427294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Icatibant is a new treatment option in life-threatening angioedema triggered by angiotensin-converting enzyme inhibitor].
    Fast S; Henningsen E; Bygum A
    Ugeskr Laeger; 2011 Oct; 173(41):2574-5. PubMed ID: 21985837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor.
    Sigler C; Annis K; Cooper K; Haber H; Van deCarr S
    Arch Dermatol; 1997 Aug; 133(8):972-5. PubMed ID: 9267242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuation of angiotensin converting enzyme inhibitor therapy, in spite of occurrence of angioedema.
    Mahmoudpour SH; Asselbergs FW; Terreehorst I; Souverein PC; de Boer A; Maitland-van der Zee AH
    Int J Cardiol; 2015 Dec; 201():644-5. PubMed ID: 26340133
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin Converting Enzyme Inhibitor-related Angioedema: A Case of an Unexpected Death.
    Atalay E; Özdemir MT; Çiğsar G; Omurca F; Aslan N; Yildiz M; Gey ZB
    Iran J Allergy Asthma Immunol; 2015 Dec; 14(6):642-5. PubMed ID: 26725563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy for Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Systematic Review.
    Lawlor CM; Ananth A; Barton BM; Flowers TC; McCoul ED
    Otolaryngol Head Neck Surg; 2018 Feb; 158(2):232-239. PubMed ID: 29112487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors.
    Gallitelli M; Alzetta M
    Am J Emerg Med; 2012 Oct; 30(8):1664.e1-2. PubMed ID: 22100478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of C1 Inhibitor for Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Angioedema Decreases Mechanical Ventilation Time.
    Urnoski E; Grillo A; Rosini JM
    J Emerg Med; 2015 Dec; 49(6):e173-5. PubMed ID: 26409672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Are AT1 receptor antagonists an alternative to ACE inhibitors in angioedema?].
    Picksak G; Stichtenoth DO
    Med Monatsschr Pharm; 2007 Nov; 30(11):415-7. PubMed ID: 18062333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitor-induced angioedema and icatibant: a new hope.
    Jacob J; Bardes I; Palom X; Carrizosa M; Fuentes E
    Intern Med J; 2015 Oct; 45(10):1093-4. PubMed ID: 26429224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.